
Global End Stage Renal Disease Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global End Stage Renal Disease market size will reach US$ million by 2031.
End-stage renal disease, also called end-stage kidney disease, occurs when chronic kidney disease — the gradual loss of kidney function — reaches an advanced state. In end-stage renal disease, kidneys are no longer able to work as they should to meet body"s needs.
Increasing number of patients suffering from renal or kidney failure and introduction of technologically advanced products, such as low maintenance dialysis equipment and artificial kidney, are the major factors expected to drive the market.
LPI (LP Information)' newest research report, the “End Stage Renal Disease Industry Forecast” looks at past sales and reviews total world End Stage Renal Disease sales in 2024, providing a comprehensive analysis by region and market sector of projected End Stage Renal Disease sales for 2025 through 2031. With End Stage Renal Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world End Stage Renal Disease industry.
This Insight Report provides a comprehensive analysis of the global End Stage Renal Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on End Stage Renal Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global End Stage Renal Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for End Stage Renal Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global End Stage Renal Disease.
This report presents a comprehensive overview, market shares, and growth opportunities of End Stage Renal Disease market by product type, application, key players and key regions and countries.
Segmentation by Type:
Transplantation
Dialysis
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Nipro Corporation
Fresenius Medical Care
Baxter International, Inc.
Medtronic Plc
B. Braun Melsungen AG
BD
Asahi Kasei Medical Co., Ltd.
Cantel Medical
Nikkiso Co., Ltd
JMS Co. Ltd.
Please note: The report will take approximately 2 business days to prepare and deliver.
End-stage renal disease, also called end-stage kidney disease, occurs when chronic kidney disease — the gradual loss of kidney function — reaches an advanced state. In end-stage renal disease, kidneys are no longer able to work as they should to meet body"s needs.
Increasing number of patients suffering from renal or kidney failure and introduction of technologically advanced products, such as low maintenance dialysis equipment and artificial kidney, are the major factors expected to drive the market.
LPI (LP Information)' newest research report, the “End Stage Renal Disease Industry Forecast” looks at past sales and reviews total world End Stage Renal Disease sales in 2024, providing a comprehensive analysis by region and market sector of projected End Stage Renal Disease sales for 2025 through 2031. With End Stage Renal Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world End Stage Renal Disease industry.
This Insight Report provides a comprehensive analysis of the global End Stage Renal Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on End Stage Renal Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global End Stage Renal Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for End Stage Renal Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global End Stage Renal Disease.
This report presents a comprehensive overview, market shares, and growth opportunities of End Stage Renal Disease market by product type, application, key players and key regions and countries.
Segmentation by Type:
Transplantation
Dialysis
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Nipro Corporation
Fresenius Medical Care
Baxter International, Inc.
Medtronic Plc
B. Braun Melsungen AG
BD
Asahi Kasei Medical Co., Ltd.
Cantel Medical
Nikkiso Co., Ltd
JMS Co. Ltd.
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
83 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 End Stage Renal Disease Market Size by Player
- 4 End Stage Renal Disease by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global End Stage Renal Disease Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.